The BRAF Mutation Is Predictive of Aggressive Clinicopathological Characteristics in Papillary Thyroid Microcarcinoma

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.17, Iss.12, 2010-12, pp. : 3294-3300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRAF Mutation in Papillary Thyroid Microcarcinoma: The Promise of Better Risk Management

By Xing Mingzhao

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 801-803

Springer Publishing Company

Access to resources Recommend Favorite

BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 791-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

Associations of the BRAF (V600E) mutation and p53 protein expression with clinicopathological features of papillary thyroid carcinomas patients

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1882-1888

Spandidos Publications

Access to resources Recommend Favorite

Ultrasonic features of papillary thyroid microcarcinoma and non-microcarcinoma

Experimental and Therapeutic Medicine, Vol. 8, Iss. 4, 2014-01 ,pp. : 1335-1339

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping Zhao Baojian Zhang Xu Gong Rixiang

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite